Skip to main content
Log in

Thallium-199: a new radiopharmaceutical for myocardial perfusion imaging

  • Original Papers
  • Published:
The International Journal of Cardiac Imaging Aims and scope Submit manuscript

Abstract

The efficacy of a new radionuclide, thallium-199 for myocardial scintigraphy was compared with conventional thallium-201 imaging. Owing to the short half-life of thallium-199 (7.4 hours), when the injected dose of thallium-199 was increased to 200 MBq, the total dose reaching the critical organs was 3.6–15.5 times lower than with conventional nuclide, thallium-201. Studies were performed in a total of 177 patients. The patients were divided into two groups (a) 17 patients with acute myocardial infarction and (b) 160 patients undergoing coronary angiography: 55 patients with no significant coronary artery disease and 105 patients with coronary disease. The sensitivity of the test was 92% with a specificity of 82% and overall predictive accuracy of 84%. Myocardial images obtained with low and high energy collimators have similar predictive accuracy. Perfusion defects were detected more frequently with increasing severity of angina. Myocardial infarction was characterized by persistent defects and myocardial ischaemia by redistribution of thallium. Thallium-199 myocardial scintigraphy performed at rest can be used for the diagnosis of acute myocardial infarction and for the determination of infarct site and extent. Thallium-199 is a new myocardial imaging agent, with a predictive accuracy for the diagnosis of coronary artery disease similar to thallium-201, but a significantly reduced total body dose permits repeat studies with a reduced radiation dose for the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lishmanov YuB, Charnov VI, Triss SV, Mazurin IYu. 199-Thallium myocardial scintigraphy. Med Radiology (Moscow) 1978; 4: 35–8 (in Russian).

    Google Scholar 

  2. Lebowitz E, Green MW, Fairchild I et al. Thallium-201 for medical use. J Nucl Med 1975; 16: 151–5.

    PubMed  Google Scholar 

  3. Bradley-Moore P, Lebowitz E, Green MW. Thallium-201 for medical use. J Nucl Med 1975; 16: 156–60.

    PubMed  Google Scholar 

  4. Lismanov Yu, Cernov VI, Krivonogov NG, Ussov VYu, Glukhov GG. Experimental investigation of thallium-199 chloride for myocardial ischaemia diagnosis. Med Nucl 1989; 1: 211–5 (in German).

    Google Scholar 

  5. Glukhov GG, Komov AI, Maslennikov YuS, Malinin AB, Skuridin VS. Thallium-199 production using accelerator U-120. In: Tarasov NF, Malinin AB, (eds). Methods of thallium isotopes production and using in Nuclear Medicine 1989: 62–68 (in Russian).

  6. Glukhov GG, Maslennikov YuS, Skuridin VS. Thallium-199 chloride production and its properties. In: Tarasov NF, Malinin AB, (eds). Methods of thallium isotopes production and using in Nuclear Medicine 1989: 68–73 (in Russian).

  7. Kochetkov VL, Gladun VT, Chumikov TN. Thallium-201 chloride production using isochrome cyclotron in Kazakh Institute of Nuclear Physics. In: Tarasov NF, Malinin AB, (eds). Methods of thallium isotopes production and using in Nuclear Medicine 1989: 58–62 (in Russian).

  8. Holman BL, Chesholm RL, Brownwald B. The prognostic implication of acute myocardial infarct scintigraphy with 99m Tc-pyrophosphate. Circulation 1978; 57: 320–6.

    PubMed  Google Scholar 

  9. Goris ML, Daspit SG, McLaughlin P, Kriss JP. Interpolative background subtraction. J Nucl Med 1976; 17: 744–7.

    PubMed  Google Scholar 

  10. Tultaev AV, Tarasenko YuI, Popov VI. Pharmacokinetic characteristics and radiation dose of thallium isotopes. In: Tarasov NF, Malinin AB, (eds). Methods of thallium isotopes production and using in Nuclear Medicine 1989: 174–86 (in Russian).

  11. Erdtmann G, Soyka W. The gamma rays of the radionuclides. Tables for applied gamma-ray spectrometry. New York: Verlag Chemie, Wienheim, 1979.

    Google Scholar 

  12. Farris JV, Burt RW, Graham MC. Thallium-201 myocardial scintigraphy: improved sensitivity, specificity and predictive accuracy by application of a statistical image analysis algorithm. Am J Cardiol 1982; 49: 733–42.

    PubMed  Google Scholar 

  13. Verani MS, Marcus ML, Razzak MA. Sensitivity and specificity of thallium-201 perfusion scintigrams under exercise and diagnosis of coronary artery disease. J Nucl Med 1978; 19: 773–82.

    PubMed  Google Scholar 

  14. Iskandrian AS, Wasserman LA, Anderson GS, Hakki H, Segai BL, Kane S. Merits of stress thallium-201 myocardial perfusion imaging in patients with inconclusive exercise electro-cardiograms: correlation with coronary arteriograms. Am J Cardiol 1980; 46: 553–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chernov, V.I., Triss, S.V., Skuridin, V.S. et al. Thallium-199: a new radiopharmaceutical for myocardial perfusion imaging. Int J Cardiac Imag 12, 119–126 (1996). https://doi.org/10.1007/BF01880743

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01880743

Key words

Navigation